Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2016 - 2025)

Agios Pharmaceuticals' Asset Utilization Ratio history spans 13 years, with the latest figure at 0.04 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 90.63% year-over-year to 0.04; the TTM value through Dec 2025 reached 0.04, up 90.63%, while the annual FY2025 figure was 0.04, 30.02% up from the prior year.
  • Asset Utilization Ratio reached 0.04 in Q4 2025 per AGIO's latest filing, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.07 in Q1 2021 to a low of 0.0 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.03, with a median of 0.03 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: crashed 99.14% in 2022, then skyrocketed 2552.53% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.03 in 2021, then crashed by 54.34% to 0.01 in 2022, then surged by 134.35% to 0.03 in 2023, then decreased by 23.42% to 0.02 in 2024, then skyrocketed by 90.63% to 0.04 in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Asset Utilization Ratio are 0.04 (Q4 2025), 0.03 (Q3 2025), and 0.03 (Q2 2025).